Back to search results

Sleep Enhancement for Older Adults with Memory Loss and Their Care Partners

This study is testing a 6-week program called Cognitive Behavioral Therapy for Insomnia (CBTi) delivered through video calls. CBTi teaches skills like relaxation and sleep hygiene to help improve sleep. We want to see if this program is practical and helpful for older adults experiencing memory loss or dementia, and their care partners, especially if both are having sleep problems. You might be able to join if you are an adult with a diagnosis of Alzheimer's Disease or related dementias, or have caregiver-reported memory issues, and have at least one sleep problem three or more times a week. We will measure changes in your insomnia, how efficiently you sleep, and how long it takes you to fall asleep to see if the program is successful. The study aims to enroll 80 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 80 participants to test a 6-week videoconference intervention.
What's involved
You would participate in one videoconference session weekly for 6 weeks. Your sleep will be measured at the start, one week after the program, and three months later.
Compensation
Not stated in the trial record.
Follow-up
Your sleep will be monitored for up to 3 months after the intervention ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06250725

Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners

Recruiting
NAAges 18+InterventionalPrevention
Emory University
~80 participants
Updated 2026-03-03 on ClinicalTrials.gov
What's tested:Cognitive Behavioral Therapy for Insomnia

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in insomnia
Measured over Baseline, 1-week post-intervention, and 3 months post-intervention
+5 more outcomes measured

Conditions

Sleep Disturbance
Dementia

Explore related trials

DementiaSleep Disorder

Where it's being run

1 sites across 1 states
Georgia1

Study leadership

  • Glenna Brewster, PhD, RN, FNP · PRINCIPAL_INVESTIGATOR · Emory University

Who to contact

Glenna S Brewster, PhD, RN, FNP
[email protected]
(404) 712-9164
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), or caregiver-reported probable or possible cognitive impairment or
Montreal Cognitive Assessment (MOCA) score between 12 and 24;
Had ≥1 sleep problem ≥3x/week on the Neuropsychiatric Inventory (NPI)-Nighttime Behavior Subscale;
Have an eligible caregiver;
Be able to participate in the intervention sessions
≥18 years old, co-residing with persons living with cognitive impairment (PLwCI);
Regularly assist the care recipient with ≥1 of 7 basic activities of daily living or
≥1 of 7 Instrumental Activities of Daily Living for the past 6 months;
Have difficulty falling asleep or difficulty staying asleep for the last three months or
Have a Pittsburgh Sleep Quality Index (PSQI) of 5 or greater

Exclusion

PLwCI: Moderate to severe cognitive impairment
Individuals who are not yet adults
Pregnant women
Prisoners
Individuals who are not able to clearly understand English.

What this trial measures

  • Change in insomniaBaseline, 1-week post-intervention, and 3 months post-intervention

    Insomnia will be measured using the Insomnia Severity Index. The insomnia severity index ahs seven questions. The seven answers are added up to get a total score. Total score categories: 0-7= No clinically significant insomnia 8-14= Subthreshold insomnia 15-21= Clinical insomnia (moderate severity) 22-28= Clinical insomnia (Severe)

  • Change in Sleep EfficiencyBaseline, 1-week post-intervention, and 3 months post-intervention

    Sleep Efficiency will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.

  • Change in in Sleep Onset LatencyBaseline, 1-week post-intervention, and 3 months post-intervention

    Sleep onset latency will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.

  • Change in Wake After Sleep OnsetBaseline, 1-week post-intervention, and 3 months post-intervention

    Wake after sleep onset will be measured using sleep diaries and actigraphy. Actigraphy watches monitor sleep-wake cycles by recording activity patterns continuously. Participants will also complete a diary each morning that asks about their sleep-wake patterns.

  • Adherence with Study Interventions (feasibility)weekly during the intervention period up to 3 months post-intervention

    Feasibility of the interventions will be assessed with rates of adherence to the study components throughout the study participation.

  • Satisfaction with intervention components1 week post-intervention

    Satisfaction with the intervention components will be assessed with the study satisfaction measure questionnaire that has 16 questions type that uses an agree, disagree scale as a range of answer options that go from strongly agree to strongly disagree.